Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mechanisms of postischemic cardiac death and protection following myocardial injury
Yusuf Mastoor, … , Elizabeth Murphy, Barbara Roman
Yusuf Mastoor, … , Elizabeth Murphy, Barbara Roman
Published January 2, 2025
Citation Information: J Clin Invest. 2025;135(1):e184134. https://doi.org/10.1172/JCI184134.
View: Text | PDF
Review

Mechanisms of postischemic cardiac death and protection following myocardial injury

  • Text
  • PDF
Abstract

Acute myocardial infarction (MI) is a leading cause of death worldwide. Although with current treatment, acute mortality from MI is low, the damage and remodeling associated with MI are responsible for subsequent heart failure. Reducing cell death associated with acute MI would decrease the mortality associated with heart failure. Despite considerable study, the precise mechanism by which ischemia and reperfusion (I/R) trigger cell death is still not fully understood. In this Review, we summarize the changes that occur during I/R injury, with emphasis on those that might initiate cell death, such as calcium overload and oxidative stress. We review cell-death pathways and pathway crosstalk and discuss cardioprotective approaches in order to provide insight into mechanisms that could be targeted with therapeutic interventions. Finally, we review cardioprotective clinical trials, with a focus on possible reasons why they were not successful. Cardioprotection has largely focused on inhibiting a single cell-death pathway or one death-trigger mechanism (calcium or ROS). In treatment of other diseases, such as cancer, the benefit of targeting multiple pathways with a “drug cocktail” approach has been demonstrated. Given the crosstalk between cell-death pathways, targeting multiple cardiac death mechanisms should be considered.

Authors

Yusuf Mastoor, Elizabeth Murphy, Barbara Roman

×

Figure 3

Molecular changes in the cell after reperfusion.

Options: View larger image (or click on image) Download as PowerPoint
Molecular changes in the cell after reperfusion.
The return of oxygen du...
The return of oxygen during reperfusion generates ROS, primarily by mitochondria (10, 11). Damage to the ETC during ischemia leads to increased ROS production on reperfusion. Complex I and complex III are the primary sites of ROS production in the mitochondria (11, 160, 202), but other sites can also contribute (203). The increase in succinate that occurs during ischemia can lead to RET through generation of ROS by complex I. Extracellular pH is rapidly restored, which promotes extrusion of intracellular H+ via NHE, leading to a transient increase in intracellular Na+. As ATP is restored, the Na+-K+ ATPase becomes active and helps to extrude intracellular Na+. Depending on the relative timing of ATP restoration, a sustained increase in cytosolic Na+ can stimulate NCX, leading to a further increase in cytosolic Ca2+ during early reperfusion. ROS can also lead to damage of intracellular proteins such as SERCA and RyR2, leading to altered SR Ca2+ homeostasis. Together, these can lead to greater Ca2+ accumulation in the cytosol and exacerbate reperfusion injury. Any increase in cytosolic Ca2+ present at the start of reperfusion would lead to an increase in mitochondrial Ca2+ accumulation via MCU when the Δψ is restored on reperfusion (204). This further increase in mitochondrial Ca2+ on reperfusion depends on how fast Δψ is restored relative to how quickly cytosolic Ca2+ returns to baseline. Ca2+ overload in the mitochondria is thought to prime the mPTP to open on reperfusion when pH is restored. It is widely cited that mPTP activation is inhibited by the acidic pH induced by ischemia (205, 206) and that upon reperfusion, intracellular and extracellular pH are rapidly corrected, allowing for mPTP opening. However, inhibition of mPTP by acidic pH only occurs in de-energized mitochondria. In energized mitochondria, low pH actually enhances mPTP opening (207). ROS is another activator of mPTP, and it is likely that the increase in ROS that occurs during reperfusion synergizes with the increase in mitochondrial Ca2+ (which may already be there during ischemia) to activate mPTP on reperfusion.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts